On Monday, a state-funded committee in Louisiana gave Mark Cuban’s Cost Plus Drug Company a taxpayer-funded microphone to ...

Independent pharmacies across the commonwealth are closing their doors, but a recent report claims the commonwealth‘s ...

Prescription drug prices are complex and vary across insurance, pharmacies, and discount platforms like GoodRx. Learn how PBMs, Medicare Part D, and new models like Cost Plus Drugs affect your costs ...

Matt Cover’s Sept. 23 op-ed sought to paint pharmacy benefit managers (PBMs) as good actors trying to keep prices low for ...

Trump issued an executive order (EO) to protect the security of the U.S. drug market by ordering a list of essential ...

The Louisiana Legislature didn't ban PBM vertical integration. But state leaders are still working on ways to limit to power ...

Doctors are experimenting with using lower doses of blockbuster cancer drugs. It could help hundreds of thousands of lives — ...

Starting October 1, the U.S. is taking a hard stance on pharmaceutical manufacturing: Imported brand-name, patented drugs ...

But plans can remove medications from their drug lists, add prior authorization restrictions and even increase deductibles ...

The potential of AI to analyse vast quantities of data in a relatively short time frame makes its application to the ...

In this week’s edition of InnovationRx, we look at a startup working to fix drug pricing, Pfizer’s obesity bet and more.

SaveHealth reports insulin has revolutionized diabetes care since its discovery, with various types enhancing patient management and flexibility.